Exhaled breath condensate as a potential specimen for diagnosing COVID-19




Maryam Khoubnasabjafari, Vahid Jouyban-Gharamaleki, Reza Ghanbari & Abolghasem Jouyban


Coronavirus disease 2019 (COVID-19) is an emerging condition threatening the biosecurity of all nations on the planet. This pandemic of respiratory disease, caused by a novel β-coronavirus (called severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]), has high sequence similarity to SARA-CoV, which was responsible for a major outbreak in 2002–2003. Early diagnosis of suspected cases is a vital task to manage patients and to control the spread of the pathogen, especially as there can be a long period before the clinical symptoms of the infection present. The current COVID-19 pandemic affects a wide range of parameters from the global economy to the personal behavior of human beings. In addition to important concerns to control the spread of the disease, further attention should be paid to the mental healthcare of members of society. At the present time, the laboratory tests to diagnosis SARS-CoV-2 samples take between a number of hours and a number of days to complete, depending on the nature of the test. Employing novel technologies, such as microfluidics, could provide a fast and accurate test for outbreaks.


April 15, 2020

View study